Posts By Alex
-
479Wire StoriesRenesas Reports Financial Results for the Second Quarter Ended June 30, 2023
TOKYO–(BUSINESS WIRE)–#Q22023Earnings–Renesas Electronics Corporation (TSE:6723) today announced consolidated financial results in accordance with IFRS for the six months ended June 30, 2023....
-
456Wire StoriesRingCentral to Double Its Workforce in India Over the Next 12 Months
Announces first office opening in Bengaluru BENGALURU, India–(BUSINESS WIRE)–RingCentral, Inc. (NYSE: RNG), a leading provider of AI-powered global enterprise cloud communications, collaboration,...
-
327Wire StoriesOncasi Cash Conducts Questionnaire on Online Casino to 167 Japanese Gambling Enthusiasts
NAGOYA, Japan–(BUSINESS WIRE)–The online casino information site “Oncasi Cash (https://airou-life.jp/)” conducted a survey on the importance of criteria for choosing an online...
-
360Wire StoriesBlack & Veatch to Advance Carbon-Neutral Aviation in Australia, New Zealand
The company joins Bioenergy Australia’s alliance as a $30 million fund is announced for sustainable aviation fuel development MELBOURNE, Australia–(BUSINESS WIRE)–Black &...
-
513Wire StoriesGradiant Partners with SpaceAge Labs to Drive Digital AI Solutions Across Total Water Infrastructure
The partnership combines Gradiant’s digital technologies for water and wastewater treatment with SpaceAge Labs’ experience in distribution networks to create a one-of-a-kind...
-
449Wire StoriesRepublic of Palau Launches US Dollar-backed Palau Stablecoin in the Next Phase of Collaboration with Ripple on the XRP Ledger
Ripple will provide the Ripple Central Bank Digital Currency Platform and technical resources in a Controlled Pilot NGERULMUD, Palau & SAN FRANCISCO–(BUSINESS...
-
441Wire StoriesChurchill Downs to Renovate Jockey Club Suites
$14 Million Project will Debut for the 150th Kentucky Derby in May 2024 LOUISVILLE, Ky., July 26, 2023 (GLOBE NEWSWIRE) — Churchill...
-
479Wire StoriesThe New England Journal of Medicine Publishes Data from Phase 2 Study of First Oral Orexin Receptor 2 Agonist TAK-994 in Patients with Narcolepsy Type 1
Trial Was Stopped Due to Hepatotoxicity and Consequently TAK-994 Program Terminated for Further Development In Patients with Narcolepsy Type 1, Oral Orexin...
-
394Wire StoriesAM Best Removes From Under Review With Developing Implications and Affirms Credit Ratings of Kommesk-Omir Life Insurance Company JSC
LONDON–(BUSINESS WIRE)–#insurance—AM Best has removed from under review with developing implications and affirmed the Financial Strength Rating of B- (Fair) and the...
-
451Wire StoriesISACA Introduces 2023-2024 Board of Directors
John De Santis, past chairman and CEO of HyTrust, will serve as board chair SCHAUMBURG, Ill.–(BUSINESS WIRE)–#isaca–Global digital trust association ISACA introduced...
